NORCROSS, Ga. and BERLIN, Oct. 04, 2022 (GLOBE NEWSWIRE) — Immucor, Inc., a global leader in transfusion and transplantation diagnostics, and Pirche AG, the global
And the PIRCHE research keeps rolling in! This week, we’re excited to showcase a paper from Spitznagel et al (University Hospital of Zurich) recently published
The countdown is on! The 2022 ASHI Conference is now under 9 weeks away and we already can’t wait to meet with you all in Las Vegas!
Some exciting publication news today! The PIRCHE-II score was shown to be a superior overall predictor of dnDSA than HLAMatchmaker in lung transplantation. Andrew Lobashevsky
PIRCHE is thrilled to announce that Bethany Dale, PhD has joined our growing team and will assume the role of Vice President Global Commercialization with effect from
The 2022 edition of the annual European Immunogenetics and Histocompatibility (EFI) Conference is just a few weeks away and we could hardly be more excited. Why? Because
PIRCHE is a proud member of the NephroCAGE consortium. The NephroCAGE project is a joint German-Canadian venture with the aim of developing a learning AI System that
February 4th marks World Cancer Day. According to statistics reported by the American Cancer Society, every year 17 million people will be diagnosed with cancer. Furthermore, 9.5
Where does the time go? Just like that, another year has flown by and the festive season is upon us again. 2021 has seen us
This website uses cookies for functionality and to make your visit better. Learn more about our privacy policy.
